Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (2024 - 2025)

Phaos Technology Holdings (Cayman) posted quarterly Shares Outstanding of $19.2 million for Q2 2025, up 1.26% year-on-year from $19.0 million in Q2 2024, and up 1.26% on a QoQ basis from $19.0 million in Q2 2024.

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Shares Outstanding data on file, last reported at $19.2 million in Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding rose 1.26% year-over-year to $19.2 million; the trailing twelve-month figure through Apr 2025 stood at $19.2 million (up 1.26% YoY), and the FY2025 full-year result was $19.2 million, up 1.26% from the prior year.
  • Shares Outstanding for Q2 2025 stood at $19.2 million, up from $19.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $11.2 million in Q2 2024 and bottomed at $7.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 2.00 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 383.40 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.75 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 660.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.90 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 459.40 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 97.80 Mn
10 Phaos Technology Holdings (Cayman) 6.83 Mn 6.73 Mn - -

Historic Data

Download Data 🔒
DateValue
Apr 30, 2025 19.25 Mn
Apr 30, 2025 19.25 Mn
Apr 30, 2025 19.25 Mn
Apr 30, 2025 19.25 Mn
Apr 30, 2025 7.93 Mn
Apr 30, 2025 7.93 Mn
Apr 30, 2025 7.93 Mn
Apr 30, 2025 7.93 Mn
Apr 30, 2024 11.23 Mn
Apr 30, 2024 11.23 Mn
Apr 30, 2024 11.23 Mn
Apr 30, 2024 11.23 Mn
Apr 30, 2024 19.01 Mn
Apr 30, 2024 19.01 Mn
Apr 30, 2024 19.01 Mn
Apr 30, 2024 19.01 Mn